Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas - A clinicomorphological study of 158 cases

Alexander Vortmeyer, J. Preuss, B. C. Padberg, H. Kastendieck, S. Schroder

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Formalin-fixed paraffin-embedded material of 158 diffuse malignant pleural mesotheliomas (DMPMs) was used in order to determine the differential diagnostic value of immunocytochemical probes against 9 different antigens. While vimentin expression was found in only 50% of cases, regardless of their histological subtype all tumours were found to be cytokeratin-positive when an antibody with broad-spectrum cytokeratin reactivity was used. Conversely, none of the cases was immunostained by antisera against carcinoembryonic antigen (CEA), Leu-M1 antigen, chromogranin A, S-100 protein, lysozyme and a T-cell associated antigen. The density of inflammatory cell infiltrates reactive with antisera against the three latter antigens was not associated with the clinical behaviour of the neoplasms examined. Eight DMPM cases showed immunoreactivity with HEA-antibodies against Egp 34, an antigen previously supposed only to be expressed by carcinomas. On the basis of these findings, the consistent cytokeratin reactivity, also of the sarcomatous type of DMPM, may help to exclude metastatic involvement of the pleura by a mesenchymal neoplasm of other origin. CEA and Leu-M1 staining of a given pleural tumour, on the other hand, is indicative of a carcinoma secondarily afflicting the pleura, thus making the diagnosis of primary DMPM unlikely.

Original languageEnglish (US)
Pages (from-to)889-894
Number of pages6
JournalAnticancer Research
Volume11
Issue number2
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Differential Diagnosis
Keratins
Antigens
Pleura
Carcinoembryonic Antigen
Immune Sera
Neoplasms
Carcinoma
Chromogranin A
S100 Proteins
Antibodies
Vimentin
Muramidase
Paraffin
Formaldehyde
Cell Count
Staining and Labeling
T-Lymphocytes
Malignant Mesothelioma

Keywords

  • differential diagnosis
  • diffuse malignant pleural mesothelioma
  • immunocytochemistry

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas - A clinicomorphological study of 158 cases. / Vortmeyer, Alexander; Preuss, J.; Padberg, B. C.; Kastendieck, H.; Schroder, S.

In: Anticancer Research, Vol. 11, No. 2, 01.01.1991, p. 889-894.

Research output: Contribution to journalArticle

@article{cf14e572317f4f2f9d34bc592ea36bfb,
title = "Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas - A clinicomorphological study of 158 cases",
abstract = "Formalin-fixed paraffin-embedded material of 158 diffuse malignant pleural mesotheliomas (DMPMs) was used in order to determine the differential diagnostic value of immunocytochemical probes against 9 different antigens. While vimentin expression was found in only 50{\%} of cases, regardless of their histological subtype all tumours were found to be cytokeratin-positive when an antibody with broad-spectrum cytokeratin reactivity was used. Conversely, none of the cases was immunostained by antisera against carcinoembryonic antigen (CEA), Leu-M1 antigen, chromogranin A, S-100 protein, lysozyme and a T-cell associated antigen. The density of inflammatory cell infiltrates reactive with antisera against the three latter antigens was not associated with the clinical behaviour of the neoplasms examined. Eight DMPM cases showed immunoreactivity with HEA-antibodies against Egp 34, an antigen previously supposed only to be expressed by carcinomas. On the basis of these findings, the consistent cytokeratin reactivity, also of the sarcomatous type of DMPM, may help to exclude metastatic involvement of the pleura by a mesenchymal neoplasm of other origin. CEA and Leu-M1 staining of a given pleural tumour, on the other hand, is indicative of a carcinoma secondarily afflicting the pleura, thus making the diagnosis of primary DMPM unlikely.",
keywords = "differential diagnosis, diffuse malignant pleural mesothelioma, immunocytochemistry",
author = "Alexander Vortmeyer and J. Preuss and Padberg, {B. C.} and H. Kastendieck and S. Schroder",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "11",
pages = "889--894",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas - A clinicomorphological study of 158 cases

AU - Vortmeyer, Alexander

AU - Preuss, J.

AU - Padberg, B. C.

AU - Kastendieck, H.

AU - Schroder, S.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Formalin-fixed paraffin-embedded material of 158 diffuse malignant pleural mesotheliomas (DMPMs) was used in order to determine the differential diagnostic value of immunocytochemical probes against 9 different antigens. While vimentin expression was found in only 50% of cases, regardless of their histological subtype all tumours were found to be cytokeratin-positive when an antibody with broad-spectrum cytokeratin reactivity was used. Conversely, none of the cases was immunostained by antisera against carcinoembryonic antigen (CEA), Leu-M1 antigen, chromogranin A, S-100 protein, lysozyme and a T-cell associated antigen. The density of inflammatory cell infiltrates reactive with antisera against the three latter antigens was not associated with the clinical behaviour of the neoplasms examined. Eight DMPM cases showed immunoreactivity with HEA-antibodies against Egp 34, an antigen previously supposed only to be expressed by carcinomas. On the basis of these findings, the consistent cytokeratin reactivity, also of the sarcomatous type of DMPM, may help to exclude metastatic involvement of the pleura by a mesenchymal neoplasm of other origin. CEA and Leu-M1 staining of a given pleural tumour, on the other hand, is indicative of a carcinoma secondarily afflicting the pleura, thus making the diagnosis of primary DMPM unlikely.

AB - Formalin-fixed paraffin-embedded material of 158 diffuse malignant pleural mesotheliomas (DMPMs) was used in order to determine the differential diagnostic value of immunocytochemical probes against 9 different antigens. While vimentin expression was found in only 50% of cases, regardless of their histological subtype all tumours were found to be cytokeratin-positive when an antibody with broad-spectrum cytokeratin reactivity was used. Conversely, none of the cases was immunostained by antisera against carcinoembryonic antigen (CEA), Leu-M1 antigen, chromogranin A, S-100 protein, lysozyme and a T-cell associated antigen. The density of inflammatory cell infiltrates reactive with antisera against the three latter antigens was not associated with the clinical behaviour of the neoplasms examined. Eight DMPM cases showed immunoreactivity with HEA-antibodies against Egp 34, an antigen previously supposed only to be expressed by carcinomas. On the basis of these findings, the consistent cytokeratin reactivity, also of the sarcomatous type of DMPM, may help to exclude metastatic involvement of the pleura by a mesenchymal neoplasm of other origin. CEA and Leu-M1 staining of a given pleural tumour, on the other hand, is indicative of a carcinoma secondarily afflicting the pleura, thus making the diagnosis of primary DMPM unlikely.

KW - differential diagnosis

KW - diffuse malignant pleural mesothelioma

KW - immunocytochemistry

UR - http://www.scopus.com/inward/record.url?scp=0025823111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025823111&partnerID=8YFLogxK

M3 - Article

C2 - 1712181

AN - SCOPUS:0025823111

VL - 11

SP - 889

EP - 894

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -